Evidence map›Paper›PMID 37387167›Full record

ArticleBioinformatics (Oxford, England)2023

Deriving spatial features from in situ proteomics imaging to enhance cancer survival analysis.

Monica T Dayao, Alexandro Trevino, Honesty Kim, Matthew Ruffalo, H Blaize D'Angio, Ryan Preska, Umamaheswar Duvvuri, Aaron T Mayer, Ziv Bar-Joseph

Abstract read
In one paragraph

Article in Bioinformatics (Oxford, England), 2023. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 13 papers.

0numbers the graph read from it
0cells of the map it votes in
13citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

13 citing papers in PubMed.

  1. Article
  2. Article
  3. Article
  4. Article
  5. Article
  6. Article
  7. Review
  8. Article
  9. Article
  10. Review
  11. A Spatial Omnibus Test (SPOT) for Spatial Proteomic Data.Bioinformatics (Oxford, England) · 2024
    Article
  12. Article
  13. A Spatial Omnibus Test (SPOT) for Spatial Proteomic Data.bioRxiv : the preprint server for biology · 2024
    Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

9 authors.

Monica T DayaoJoint Carnegie Mellon University-University of Pittsburgh Ph.D. Program in Computational Biology, Pittsburgh, PA 15213, United States.
Alexandro TrevinoEnable Medicine, Menlo Park, CA 94025, United States.
Honesty KimEnable Medicine, Menlo Park, CA 94025, United States.
Matthew RuffaloComputational Biology Department, Carnegie Mellon University, Pittsburgh, PA 15213, United States.
H Blaize D'AngioEnable Medicine, Menlo Park, CA 94025, United States.
Ryan PreskaEnable Medicine, Menlo Park, CA 94025, United States.
Umamaheswar DuvvuriDepartment of Otolaryngology, University of Pittsburgh, Pittsburgh, PA 15213, United States.
Aaron T MayerEnable Medicine, Menlo Park, CA 94025, United States.
Ziv Bar-JosephComputational Biology Department, Carnegie Mellon University, Pittsburgh, PA 15213, United States.

Funding

SenNet Supplement - Consortium BenchmarkingU24CA268108 · NCI · UNIVERSITY OF PITTSBURGH AT PITTSBURGH · PI Philip D. Blood, JONATHAN C. SILVERSTEIN · 2021 to 2026
$22.1M
TriState SenNET (Lung and Heart) Tissue Map and Atlas consortiumU54AG075931 · NIA · UNIVERSITY OF PITTSBURGH AT PITTSBURGH · PI TOREN FINKEL, Melanie Koenigshoff · 2021 to 2026
$14.0M
Integrated Interdisciplinary, inter-university PhD Program Computational Biology (T32)T32EB009403 · NIBIB · UNIVERSITY OF PITTSBURGH AT PITTSBURGH · PI BAHAR, IVET, BAR-JOSEPH, ZIV · 2009 to 2023
$4.4M
Comprehensive, Flexible and FAIR Tools for the HuBMAP HIVEOT2OD026682 · OD · CARNEGIE-MELLON UNIVERSITY · PI PATEN, BENEDICT, RUFFALO, MATTHEW · 2018 to 2021
$3.4M
Toward a Deeper Understanding of Allostery and Allotargeting by Computational ApproachesR01GM139297 · NIGMS · UNIVERSITY OF PITTSBURGH AT PITTSBURGH · PI Ivet Bahar · 2021 to 2026
$2.8M
Machine learning methods for the analysis and modeling of spatial proteomics dataF31LM014194 · NLM · CARNEGIE-MELLON UNIVERSITY · PI DAYAO, MONICA · 2023 to 2024
$97k
NCI NIH HHS U24 CA268108NIA NIH HHS U54 AG075931NIBIB NIH HHS T32 EB009403NIGMS NIH HHS R01 GM139297NIH HHS F31LM014194NIH HHS OT2 OD026682NLM NIH HHS F31 LM014194
6 · The paper itself

Abstract

motivationSpatial proteomics data have been used to map cell states and improve our understanding of tissue organization. More recently, these methods have been extended to study the impact of such organization on disease progression and patient survival. However, to date, the majority of supervised learning methods utilizing these data types did not take full advantage of the spatial information, impacting their performance and utilization.

resultsTaking inspiration from ecology and epidemiology, we developed novel spatial feature extraction methods for use with spatial proteomics data. We used these features to learn prediction models for cancer patient survival. As we show, using the spatial features led to consistent improvement over prior methods that used the spatial proteomics data for the same task. In addition, feature importance analysis revealed new insights about the cell interactions that contribute to patient survival. AVAILABILITY AND IMPLEMENTATION: The code for this work can be found at gitlab.com/enable-medicine-public/spatsurv.

Indexed as

NeoplasmsProteomicsCell CommunicationDisease ProgressionHumansSurvival Analysis

Identifiers

PMID37387167
PMCPMC10311350

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.